|
|||||
|
|
| 骨髓增殖性肿瘤发病机制及风险分层研究进展:第56届美国血液学会年会报道 | |
| 引用本文： | 张陆阳,潘崚. 骨髓增殖性肿瘤发病机制及风险分层研究进展:第56届美国血液学会年会报道[J]. 白血病．淋巴瘤, 2015, 24(3): 147-151. DOI: 10.3760/cma.j.issn.1009-9921.2015.03.006 |
| 作者姓名： | 张陆阳 潘崚 |
| 作者单位： | 四川大学华西医院血液科, 成都,610041 |
| 摘 要： | 近年,关于bcr-abl阴性的骨髓增殖性肿瘤(MPN),无论在发病机制、诊断、风险分层还是靶向治疗等方面,都有了长足进步.文章就2014年第56届美国血液学会年会上展示的关于bcr-abl阴性MPN的发病机制、诊断及风险分层研究进展进行介绍. |
| 关 键 词： | 骨髓增殖性肿瘤 发病机制 症状评估 美国血液学会年会 |
Advances in the genesis and risk stratification of myeloproliferative neoplasms: reports from the 56th American Society of Hematology annual meeting |
|
| Zhang Luyang,Pan Ling. Advances in the genesis and risk stratification of myeloproliferative neoplasms: reports from the 56th American Society of Hematology annual meeting[J]. Journal of Leukemia & Lymphoma, 2015, 24(3): 147-151. DOI: 10.3760/cma.j.issn.1009-9921.2015.03.006 | |
| Authors: | Zhang Luyang Pan Ling |
| Abstract: | Great advances have been made in understanding the genesis,diagnosis,risk stratification and the targeted therapy of myeloproliferative neoplasms (MPNs) in the past decade.This article reviews the current situation in the genesis,diagnosis and risk stratification of these classic bcr-abl-negative MPNs presented in the 56th American Society of Hematology (ASH) annual meeting. |
| Keywords: | Myeloproliferative neoplasm Pathogenesis Symptom assessment American Society of Hematology annual meeting |
| 本文献已被 万方数据 等数据库收录！ | |